Anti-Glaxo campaign heats up in United StatesBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7386.413 (Published 22 February 2003) Cite this as: BMJ 2003;326:413
- Ray Moynihan
Pharmaceutical giant GlaxoSmithKline is facing a growing backlash over its decision to cut supplies to Canadian pharmacies selling cheap drugs into the United States.
In recent years elderly Americans have been making much publicised bus trips across the border and using online pharmacies to buy drugs from Canada, where they cost anything from half to a sixth the price in the United States.
In late January GlaxoSmithKline announced it was suspending sales to Canadian wholesalers and pharmacies that exported drugs to prevent what it described as “illegal, potentially unsafe …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial